Covid: Oxford-AstraZeneca jab protection against South Africa variant ‘limited’, study suggests: Early findings from a small study point to limited protection against mild disease caused by S Africa variant.
Source: “South Africa” – BingNews
Oxford vaccine ‘significantly less effective against South Africa variant’, study suggests: AstraZeneca says its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data …
Source: “South Africa” – BingNews
